Aclaris Therapeutics Inc. (ACRS)
NASDAQ: ACRS
· Real-Time Price · USD
1.44
-0.03 (-2.04%)
At close: Jun 16, 2025, 3:59 PM
1.42
-1.39%
After-hours: Jun 16, 2025, 07:47 PM EDT
-2.04% (1D)
| Bid | 1.41 |
| Market Cap | 155.92M |
| Revenue (ttm) | 17.78M |
| Net Income (ttm) | -130.21M |
| EPS (ttm) | -1.59 |
| PE Ratio (ttm) | -0.91 |
| Forward PE | -2.3 |
| Analyst | Buy |
| Ask | 1.47 |
| Volume | 549,251 |
| Avg. Volume (20D) | 849,031 |
| Open | 1.48 |
| Previous Close | 1.47 |
| Day's Range | 1.44 - 1.53 |
| 52-Week Range | 1.05 - 5.17 |
| Beta | 0.42 |
About ACRS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACRS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACRS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+11.02%
Aclaris Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
1 month ago
-2.65%
Aclaris shares are trading higher after the company announced FDA clearance of its IND application for a Phase 1A/1B trial of ATI-052.
